Bryan Kobel is the founder of TC BioPharm. TC BioPharm has raised $6M in total funding. Latest round: Growth. Backed by ScaleReady.
Bryan Kobel is the Chief Executive Officer of TC BioPharm Holdings, a publicly traded clinical-stage cell therapy company. He transitioned from investment banking to lead this biotech firm, which is developing allogeneic gamma-delta T cell therapies for cancer and infectious diseases. The company has reported human efficacy data in acute myeloid leukemia (AML).
Full founder directory · Investor directory · Company funding database · Fundraising library